Cell kinetics as a prognostic marker in locally advanced breast cancer

R. Silvestrini, M. G. Daidone, P. Valagussa, B. Salvadori, D. Rovini, G. Bonadonna

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

The study analyzes the prognostic implication of cell kinetics on 52 locally advanced breast cancers. All patients were subjected to a multimodal treatment, including primary chemotherapy with doxorubicin and vincristine, surgery, or radiotherapy followed by additional chemotherapy with the same drug regimen. Pretreatment labeling index (LI) is not related to response to primary chemotherapy, whereas it provides information on the course of the disease. In fact, high LI significantly predicts a higher progression rate at the end of the entire combined treatment, a shorter time to disease progression, and a poorer probability of 4-year survival in comparison to low LI. From the present findings, LI appears to be a useful tool to select women with locally advanced breast cancer that would require very aggressive treatment.

Original languageEnglish
Pages (from-to)375-379
Number of pages5
JournalCancer Treatment Reports
Volume71
Issue number4
Publication statusPublished - 1987

Fingerprint

Breast Neoplasms
Drug Therapy
Combined Modality Therapy
Vincristine
Doxorubicin
Disease Progression
Radiotherapy
Survival
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Silvestrini, R., Daidone, M. G., Valagussa, P., Salvadori, B., Rovini, D., & Bonadonna, G. (1987). Cell kinetics as a prognostic marker in locally advanced breast cancer. Cancer Treatment Reports, 71(4), 375-379.

Cell kinetics as a prognostic marker in locally advanced breast cancer. / Silvestrini, R.; Daidone, M. G.; Valagussa, P.; Salvadori, B.; Rovini, D.; Bonadonna, G.

In: Cancer Treatment Reports, Vol. 71, No. 4, 1987, p. 375-379.

Research output: Contribution to journalArticle

Silvestrini, R, Daidone, MG, Valagussa, P, Salvadori, B, Rovini, D & Bonadonna, G 1987, 'Cell kinetics as a prognostic marker in locally advanced breast cancer', Cancer Treatment Reports, vol. 71, no. 4, pp. 375-379.
Silvestrini R, Daidone MG, Valagussa P, Salvadori B, Rovini D, Bonadonna G. Cell kinetics as a prognostic marker in locally advanced breast cancer. Cancer Treatment Reports. 1987;71(4):375-379.
Silvestrini, R. ; Daidone, M. G. ; Valagussa, P. ; Salvadori, B. ; Rovini, D. ; Bonadonna, G. / Cell kinetics as a prognostic marker in locally advanced breast cancer. In: Cancer Treatment Reports. 1987 ; Vol. 71, No. 4. pp. 375-379.
@article{c52f94dfe9ea44c2bd00aa263a3c4c26,
title = "Cell kinetics as a prognostic marker in locally advanced breast cancer",
abstract = "The study analyzes the prognostic implication of cell kinetics on 52 locally advanced breast cancers. All patients were subjected to a multimodal treatment, including primary chemotherapy with doxorubicin and vincristine, surgery, or radiotherapy followed by additional chemotherapy with the same drug regimen. Pretreatment labeling index (LI) is not related to response to primary chemotherapy, whereas it provides information on the course of the disease. In fact, high LI significantly predicts a higher progression rate at the end of the entire combined treatment, a shorter time to disease progression, and a poorer probability of 4-year survival in comparison to low LI. From the present findings, LI appears to be a useful tool to select women with locally advanced breast cancer that would require very aggressive treatment.",
author = "R. Silvestrini and Daidone, {M. G.} and P. Valagussa and B. Salvadori and D. Rovini and G. Bonadonna",
year = "1987",
language = "English",
volume = "71",
pages = "375--379",
journal = "Cancer Treatment Reports",
issn = "0361-5960",
publisher = "U.S. National Cancer Institute",
number = "4",

}

TY - JOUR

T1 - Cell kinetics as a prognostic marker in locally advanced breast cancer

AU - Silvestrini, R.

AU - Daidone, M. G.

AU - Valagussa, P.

AU - Salvadori, B.

AU - Rovini, D.

AU - Bonadonna, G.

PY - 1987

Y1 - 1987

N2 - The study analyzes the prognostic implication of cell kinetics on 52 locally advanced breast cancers. All patients were subjected to a multimodal treatment, including primary chemotherapy with doxorubicin and vincristine, surgery, or radiotherapy followed by additional chemotherapy with the same drug regimen. Pretreatment labeling index (LI) is not related to response to primary chemotherapy, whereas it provides information on the course of the disease. In fact, high LI significantly predicts a higher progression rate at the end of the entire combined treatment, a shorter time to disease progression, and a poorer probability of 4-year survival in comparison to low LI. From the present findings, LI appears to be a useful tool to select women with locally advanced breast cancer that would require very aggressive treatment.

AB - The study analyzes the prognostic implication of cell kinetics on 52 locally advanced breast cancers. All patients were subjected to a multimodal treatment, including primary chemotherapy with doxorubicin and vincristine, surgery, or radiotherapy followed by additional chemotherapy with the same drug regimen. Pretreatment labeling index (LI) is not related to response to primary chemotherapy, whereas it provides information on the course of the disease. In fact, high LI significantly predicts a higher progression rate at the end of the entire combined treatment, a shorter time to disease progression, and a poorer probability of 4-year survival in comparison to low LI. From the present findings, LI appears to be a useful tool to select women with locally advanced breast cancer that would require very aggressive treatment.

UR - http://www.scopus.com/inward/record.url?scp=0023259964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023259964&partnerID=8YFLogxK

M3 - Article

VL - 71

SP - 375

EP - 379

JO - Cancer Treatment Reports

JF - Cancer Treatment Reports

SN - 0361-5960

IS - 4

ER -